CanaFarma with Frank Barone, Chief Operating Officer. With CBD widely popular in many consumer products due to the passing of the Farm Bill in 2018 that legalized industrial hemp, the industry still faces legal challenges and gray areas. The FDA is thoroughly reviewing CBD in an effort to release regulations and guidelines soon once there is a better understanding. CanaFarma is a burgeoning company that has effectively re-arranged the vector of pop culture in only a few months. The executives at the New York-based firm (which is listed on the Canadian Securities Exchange: CNFA) decided to court one of the entertainment industry´s biggest power brokers. By successfully recruiting Gibson Kagni – an award-winning music producer and the strategist behind some of the most successful consumer brands of the last decade - CanaFarma effectively acquired an all-access pass to modern popular culture. Through Mr. Kagni´s connections and his proactive involvement as a shareholder, the company has been able to secure marquee product development partnerships such as a deal with social media superstar "Food god" which was unveiled recently.
Enjoy this episode?
Subscribe to Blunt Business for new episodes.
More from Blunt Business
A Psychedelic and Cannabis Research Revolution On the Horizon?
Blunt Business
This episode of Blunt Business explores a significant shift in federal drug policy following a new executive order aimed at accelerating research into psychedelics like LSD, psilocybin, and ibogaine for treating mental health disorders.